Fox Chase Cancer Center operates as a cancer research and treatment center in the United States. It provides diagnostic, treatment, research, and prevention services in the areas of breast, colon, lung, and prostate cancer. The company also provides breast evaluation, risk assessment, and diagnostic imaging services; and breast, gynecologic, and ovarian cancer research programs. In addition, it offers screening services, including prevention screening, mammography, skin cancer, Barrett’s esophagus, and open access endoscopy services. Further, the company conducts basic, translational, and clinical research with special programs in cancer prevention, detection, survivorship, and community out...
333 Cottman Avenue
Philadelphia, PA 19111-2497
Founded in 1904
Fox Chase Cancer Center Appoints Richard I. Fisher as President and CEO
Aug 4 13
Richard I. Fisher, MD has been appointed President and CEO of Fox Chase Cancer Center. Fisher will also hold the title of Cancer Center Director of Fox Chase, serving as the principal investigator on the Cancer Center Support Grant (CCSG) from the National Cancer Institute. He will retain the title of Senior Associate Dean for Cancer Programs at Temple University School of Medicine. Since his arrival, Kaiser noted, Fisher has demonstrated extraordinarily adroit and sure-handed leadership and administrative ability, working closely with leaders at Fox Chase and across Temple Health. He has helped to advance a positive and forward-looking perspective that will help to reinvigorate clinical and scientific cancer programs and to launch vital faculty recruitment efforts. Before joining Fox Chase and Temple Health, Fisher was Vice President for Strategic and Program Development at the University of Rochester Medical Center and the Samuel E. Durand Professor of Medicine.